Sociedad Qu edmica y Minera de Chile S.A. (SQM) presents consolidated interim financial statements for the six months ended June 30, 2025 and comparative periods. Total assets were ThUS$11,524,036 with total equity of ThUS$5,393,685 and total liabilities of ThUS$6,130,351. For January to June 2025 revenue was ThUS$2,079,307 and gross profit ThUS$558,264. SQM reported net income of ThUS$227,720 for the period, a reversal from a net loss of ThUS$653,860 in the prior-year period, driven after income tax expense of ThUS$130,958 in 2025 versus a large tax expense in 2024. Cash and cash equivalents were ThUS$1,565,586 at June 30, 2025 and current inventories were ThUS$1,851,147. The Joint Venture Agreement with Codelco is disclosed but not effective as of the reporting date and, if conditions are met in 2025, would reclassify certain amounts to non-controlling interests and create a dividend payable to Codelco calculated by an agreed methodology.
Sociedad Quimica y Minera de Chile S.A. (SQM) reports select metrics for mid-2025. The company indicated it files annual reports on Form 20-F and provided an address for its principal executive office in Santiago, Chile. The Lithium and Derivatives segment reported an adjusted gross margin of 21% for Q2 2025. In Specialty Plant Nutrition (SPN), revenue for the six months ended June 30, 2025 was US$472.6 million, slightly above US$468.2 million for the same period in 2024. SPN revenue for Q2 2025 was US$260.3 million, essentially flat versus US$260.5 million in Q2 2024.